Ascorbic acid prices erode Zila's profits
Zila, a US pharma and biotech company, has achieved double-digit sales growth for the first half of 2004, mainly due to the performance of its nutraceutical division. Operational costs exceeded sales however, due to higher cost of ascorbic acid and...